Hot Topics in Pharmacy: A Comparison of Vancomycin and Linezolid for Empiric MRSA Coverage

This podcast evaluates the roles of intravenously (IV) administered vancomycin and IV or orally (PO) administered linezolid for the empiric management of suspected or confirmed infections caused by methicillin-resistant Staphylococcus aureus (MRSA). We discuss and compare the positive and negative attributes of each drug and how those impact their places in the therapeutic management of MRSA infections. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.